Clinical Trial Update: Randomized Study of Plasmapheresis or Human Immunoglobulin Infusion in Childhood Guillain-Barre Syndrome [NA]

View source ↗

Summary

A randomized trial comparing plasmapheresis to intravenous immunoglobulin in children with Guillain-Barré syndrome was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Guillain-barré Syndrome

Drugs mentioned

• Intravenous Immunoglobulin (IVIG)
• plasmapheresis

Snippet

Sponsor: Emory University | Conditions: Guillain-Barre Syndrome | NA | Status: TERMINATED